Towards clinically translatable in vivo nanodiagnostics

S Park, A Aalipour, O Vermesh, JH Yu… - Nature Reviews …, 2017 - nature.com
Nanodiagnostics as a field makes use of fundamental advances in nanobiotechnology to
diagnose, characterize and manage disease at the molecular scale. As these strategies …

Development of 225Ac radiopharmaceuticals: TRIUMF perspectives and experiences

AKH Robertson, CF Ramogida… - Current …, 2018 - ingentaconnect.com
Background: The development of radiopharmaceuticals containing 225Ac for targeted alpha
therapy is an active area of academic and commercial research worldwide. Objectives …

Organotrifluoroborate enhances tumor targeting of fibroblast activation protein inhibitors for targeted radionuclide therapy

Y Liu, H Tang, T Song, M Xu, J Chen, XY Cui… - European Journal of …, 2023 - Springer
Purpose Fibroblast activation protein (FAP) is a pan-cancer target and now the state-of-the-
art to develop radiopharmaceuticals. FAP inhibitors have been of great success in …

Multi-isotope SPECT imaging of the 225Ac decay chain: feasibility studies

AKH Robertson, CF Ramogida… - Physics in Medicine …, 2017 - iopscience.iop.org
Abstract Effective use of the ${}^{225}{\rm Ac} $ decay chain in targeted internal
radioimmunotherapy requires the retention of both ${}^{225}{\rm Ac} $ and progeny isotopes …

[HTML][HTML] Improved safety and efficacy of 213 Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated …

HS Chan, MW Konijnenberg, T Daniels, M Nysus… - EJNMMI research, 2016 - Springer
Background Targeted alpha therapy (TAT) offers advantages over current β-emitting
conjugates for peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors …

Bi-DTPA as a high-performance CT contrast agent for in vivo imaging

W Liao, P Lei, J Pan, C Zhang, X Sun, X Zhang, C Yu… - Biomaterials, 2019 - Elsevier
Clinically used iodinated computer tomography (CT) contrast agents suffer from low
sensitivity, and the emerging lanthanide-chelates and CT imaging nanoagents raise great …

Cyclotron-produced 132La as a PET imaging surrogate for therapeutic 225Ac

E Aluicio-Sarduy, TE Barnhart, J Weichert… - Journal of Nuclear …, 2021 - Soc Nuclear Med
The aim of this work was to explore 132La as a PET imaging surrogate for 225Ac using a
DOTA-based, tumor-targeting alkylphosphocholine (NM600). Methods: 132La was …

An octadentate bis (semicarbazone) macrocycle: a potential chelator for lead and bismuth radiopharmaceuticals

JL Lange, PRWJ Davey, MT Ma, JM White… - Dalton …, 2020 - pubs.rsc.org
A variant of 1, 4, 7, 10-tetraazacyclododecane (cyclen) bearing two semicarbazone pendant
groups has been prepared. The octadentate ligand forms complexes with Bi3+ and Pb2+. X …

Positron range-free and multi-isotope tomography of positron emitters

FJ Beekman, C Kamphuis… - Physics in Medicine …, 2021 - iopscience.iop.org
Despite improvements in small animal PET instruments, many tracers cannot be imaged at
sufficiently high resolutions due to positron range, while multi-tracer PET is hampered by the …

Bi 2 SiO 5@ g-SiO 2 upconverting nanoparticles: a bismuth-driven core–shell self-assembly mechanism

M Back, E Trave, G Zaccariello, D Cristofori, P Canton… - Nanoscale, 2019 - pubs.rsc.org
Core–shell systems have attracted increasing interest among the research community in
recent years due to their unique properties and structural features, and the development of …